Streetbeat News

Corporate Responsibility

GOEV

Canoo has postponed its Annual Shareholder Meeting to December 29, 2023, to allow more time to solicit votes necessary to reach a quorum and proceed with company business.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 9:19 pm

LESL

Leslie's, Inc. (NASDAQ:LESL) announced board changes with Steven L. Ortega retiring at the 2024 Annual Meeting and not seeking reelection. John Strain is now Lead Independent Director and Chairman-Elect, while James Ray, Jr. stepped down from the board. Ortega's retirement follows nearly two decades of service, including as CEO and President. Under his leadership, Leslie's surpassed 1,000 stores and went public. Strain, with over 30 years in retail technology and e-commerce, aims to drive profitable growth. The board size will decrease from nine to eight immediately, and to seven in 2024.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 9:15 pm

SPCE

Virgin Galactic Holdings, Inc. (NYSE:SPCE) has announced the opening of the 'Galactic 06' flight window on January 26, 2024. This marks the company's 11th spaceflight and follows a year with six suborbital spaceflights in six months. The upcoming commercial spaceflight will carry four private astronauts from Ukraine/California, Texas, Austria, and California. The crew includes VSS Unity Commander CJ Sturckow, pilot Nicola Pecile, VMS Eve Commander Michael Masucci, and pilot Dan Alix. CEO Michael Colglazier highlighted the company's achievements and the safe customer experience provided.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 9:12 pm

FDX

FedEx maintains its adjusted earnings outlook for the fiscal year, expecting EPS of $17.00-$18.50, which is in line with the $18.25 estimate. The company anticipates a low-single-digit percentage decline in revenue year over year and projects capital spending of $5.7 billion focused on efficiency improvements. FedEx is unable to provide a GAAP EPS or ETR outlook for fiscal 2024 due to uncertainties in mark-to-market retirement plan adjustments.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 9:09 pm

MEI

Methode Electronics has announced the appointment of Avi Avula as its new President and CEO, effective January 29, 2024. Avula will succeed the current CEO, Donald Duda.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 9:08 pm

ACRS

Aclaris Therapeutics announced it is reducing spending and streamlining its organization by discontinuing the development of ATI-450, a treatment for immuno-inflammatory diseases. This decision is part of the company's efforts to focus resources more effectively.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 9:08 pm

LANC

Lancaster Colony has announced the appointment of Alan F. Harris as the Chairman of the Board, effective January 1, 2024. The current Chairman, John B. Gerlach, will continue to serve as a member of the board.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 9:01 pm

ALTM

LTHM

Livent Corporation (NYSE:LTHM) and Allkem Limited (ASX, TSX:AKE) have received all necessary shareholder approvals to complete their previously announced merger of equals. The merger is expected to close on January 4, 2024, and the combined entity will operate under the name Arcadium Lithium plc and trade on the NYSE under the ticker 'ALTM'. The merger is seen as a transformational move that aims to create greater long-term, sustainable value for stakeholders.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 8:58 pm

CRM

Slack, a business communication platform, is experiencing significant leadership changes as three executives, including the Chief Operating Officer (COO), are departing from the company. This development follows after the acquisition of Slack by Salesforce (CRM). The departure of key executives could signal internal shifts or strategic realignments within Slack, which is now a part of Salesforce's suite of services.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 8:28 pm

CMPS

The debate on whether psychedelic treatments require psychotherapy is ongoing, with COMPASS Pathways' Dr. Guy Goodwin suggesting that the effects of psilocybin are primarily due to the drug itself, not psychotherapy. He argues for a neutral terminology and acknowledges the dose-response relationship of psilocybin. Meanwhile, Dr. Max Wolff of the MIND Foundation insists that psychotherapy is integral to effective psychedelic treatments, citing COMPASS' trial protocols that emphasize therapeutic processes and require therapists to be licensed healthcare practitioners. The discussion highlights differing views on the role of psychotherapy in psychedelic treatments within a clinical setting.

Portfolio Pulse from Lara Goldstein

December 19, 2023 | 7:44 pm